K2 and Beyond: A Synthetic Cannabinoid Primer

The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry

The Challenges of Analytical Method Validation for Hallucinogens and Designer Stimulants in Biological Samples Using LC-TOF

Developments in Toxicology Support for the DRE Community

Pharmacodynamics and Pharmacokinetics of Synthetic Cannabinoids

Increasing Diversity of Chemicals in Synthetic Stimulant and Cathinone Cases

Oral Fluid as a Chemical Test for the DRE Program

K2 and the Synthetic Cannabinoids: Pharmacology, Effects and Chemical Analysis

Trends Report on Changes in the Designer Drug Market: Spring 2012

New Highs: Salvia and K 2 - Solutions for the DRE

NMS Labs introduction

Designer Drugs Testing Solutions for Employers

Salvia: Effects, Legal Status and Analysis

Testing for BPA and other EDCs

NMS Labs Dinner Presentation by Dr. Andrea Gore 5-27-10

Julie Ruth Resume January 2017